Current evidence supports the use of combination therapy in the management of benign prostatic hyperplasia

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.28, Iss.12, 2012-12, pp. : 5-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Therapy for the Pharmacological Management of Benign Prostatic Hyperplasia: Rationale and Treatment Options

By Sandhu Jaspreet S.  

Drugs & Aging, Vol. 22, Iss. 11, 2005-01 ,pp. : 901-912

Adis International

Access to resources Recommend Favorite

Combination Pharmacological Therapies for the Management of Benign Prostatic Hyperplasia

By Cohen Seth A.   Parsons J. Kellogg  

Drugs & Aging, Vol. 29, Iss. 4, 2012-04 ,pp. : 275-284

Adis International

Access to resources Recommend Favorite

Finasteride: An Update of its Use in the Management of Symptomatic Benign Prostatic Hyperplasia

By Wilde M.I.   Goa K.L.  

Drugs, Vol. 57, Iss. 4, 1999-04 ,pp. : 557-581

Adis International

Access to resources Recommend Favorite

Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1209-1211

Informa Healthcare

Access to resources Recommend Favorite

Current concepts in the pharmacotherapy of benign prostatic hyperplasia

By Khastgir Jay   Arya Manit   Shergill Iqbal S   Kalsi Jas S   Minhas Sux   Mundy AnthonyR  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1727-1737

Informa Healthcare

Access to resources Recommend Favorite